Tag: Daiichi Sankyo

Cancer-associated VTE trial sees “lower rate of recurrent VTE with edoxaban...

Daiichi Sanyoko has announced the results from their Hokusai-VTE CANCER trial evaluating the direct oral anticoagulant edoxaban for treatment of venous thromboembolism (VTE) in...

First patient enrolled in Daiichi Sankyo European edoxaban registry

The first patient has been enrolled in Daiichi Sankyo’s EMIT-AF/VTE (Edoxaban Management in Diagnostic and Therapeutic Procedures) study. This registry will collect real-world clinical...